Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months
Apply
Intranasal Vaccine
Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step